Kevin Watanabe‐Smith

2.3k total citations
13 papers, 267 citations indexed

About

Kevin Watanabe‐Smith is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kevin Watanabe‐Smith has authored 13 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Kevin Watanabe‐Smith's work include Acute Myeloid Leukemia Research (8 papers), Autophagy in Disease and Therapy (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Kevin Watanabe‐Smith is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Autophagy in Disease and Therapy (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Kevin Watanabe‐Smith collaborates with scholars based in United States, Switzerland and India. Kevin Watanabe‐Smith's co-authors include Jeffrey Tyner, Shannon K. McWeeney, Qing‐Shuo Zhang, Markus Grompe, William H. Fleming, Andrew W. Duncan, Devorah C. Goldman, Grover C. Bagby, R. Keaney Rathbun and Cristina E. Tognon and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Kevin Watanabe‐Smith

12 papers receiving 264 citations

Peers

Countries citing papers authored by Kevin Watanabe‐Smith

Since Specialization

Citations

This map shows the geographic impact of Kevin Watanabe‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Watanabe‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Watanabe‐Smith more than expected).

Fields of papers citing papers by Kevin Watanabe‐Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Watanabe‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Watanabe‐Smith. The network helps show where Kevin Watanabe‐Smith may publish in the future.

Co-authorship network of co-authors of Kevin Watanabe‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Watanabe‐Smith. A scholar is included among the top collaborators of Kevin Watanabe‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Watanabe‐Smith. Kevin Watanabe‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients 2020 ·Oncotarget ·Mara Rosenberg, Kevin Watanabe‐Smith, Jeffrey Tyner, Cristina E. Tognon, Brian Druker, Uma Borate	6
2	Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms 2020 ·Blood ·Sunil K. Joshi, (unknown), William H. Bisson, Kevin Watanabe‐Smith, (unknown), Daniel Bottomly, Elie Traer, Jeffrey Tyner, Shannon K. McWeeney, Monika A. Davare, Brian Druker, Cristina E. Tognon	25
3	Gain-of-function mutations in granulocyte colony–stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation 2018 ·Journal of Biological Chemistry ·Haijiao Zhang, Cody Coblentz, Kevin Watanabe‐Smith, (unknown), (unknown), Julia E. Maxson, Jeffrey Tyner	29
4	CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells 2018 ·Blood ·David K. Edwards, Kevin Watanabe‐Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam J. Lamble, Evan Lind, Andy Kaempf, Motomi Mori, Mara Rosenberg, Amanda d’Almeida, Nicola Long, Anupriya Agarwal, (unknown), Marc Loriaux, Shannon K. McWeeney, Jeffrey Tyner	82
5	RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples 2018 ·Blood ·Mara Rosenberg, Cristina E. Tognon, Kevin Watanabe‐Smith, Uma Borate	1
6	Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function 2017 ·Cancer Research ·Haijiao Zhang, (unknown), Anna Reister Schultz, Kevin Watanabe‐Smith, Bruno C. Medeiros, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, (unknown), Oliver Hantschel, Jeffrey Tyner	10
7	Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations 2017 ·Oncotarget ·Kevin Watanabe‐Smith, (unknown), Anupriya Agarwal, Cristina E. Tognon, Brian Druker	8
8	A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes 2015 ·Blood ·Kevin Watanabe‐Smith, Cristina E. Tognon, Jeffrey Tyner, Brian Druker, Anupriya Agarwal	0
9	Exome Sequencing Informs Mechanisms of Clinical Resistance to the FLT3-D835 Inhibitor Crenolanib 2015 ·Blood ·Haijiao Zhang, Kevin Watanabe‐Smith, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Hagop M. Kantarjian, Judy Ho, Jeremy L. Davis, (unknown), Gautam Borthakur, Abhijit Ramachandran, Jörge E. Cortes, Robert H. Collins, Jeffrey Tyner	3
10	Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia 2014 ·Oncogene ·(unknown), (unknown), Christopher A. Eide, Monika A. Davare, Kevin Watanabe‐Smith, Cristina E. Tognon, Solange Mongoue‐Tchokote, (unknown), Rita M. Braziel, Jeffrey Tyner, Brian Druker	10
11	Evaluation of resveratrol and N‐acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model 2013 ·Pediatric Blood & Cancer ·Qing‐Shuo Zhang, (unknown), Andrea M. Sheehan, Kevin Watanabe‐Smith, (unknown), Eric Benedetti, Angela M. Major, Kathryn Schubert, (unknown), Eric W. Joseph, Markus Grompe	12
12	Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice 2013 ·Stem Cell Research ·Qing‐Shuo Zhang, Kevin Watanabe‐Smith, Kathryn Schubert, Angela M. Major, Andrea M. Sheehan, (unknown), Amy E. Hanlon Newell, Eric Benedetti, Eric W. Joseph, Susan B. Olson, Markus Grompe	8
13	Fancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol 2010 ·Blood ·Qing‐Shuo Zhang, (unknown), (unknown), Andrew W. Duncan, Devorah C. Goldman, (unknown), Kevin Watanabe‐Smith, R. Keaney Rathbun, William H. Fleming, Grover C. Bagby, Markus Grompe	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact